These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1546695

  • 1. Flow cytometric analysis of endometrial stromal sarcoma.
    Hitchcock CL, Norris HJ.
    Am J Clin Pathol; 1992 Feb; 97(2):267-71. PubMed ID: 1546695
    [Abstract] [Full Text] [Related]

  • 2. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.
    Genest DR, Sheets E, Lage JM.
    Am J Clin Pathol; 1994 Sep; 102(3):341-8. PubMed ID: 8085558
    [Abstract] [Full Text] [Related]

  • 3. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
    Terada K, Mattson D, Goo D, Shimizu D.
    Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
    [Abstract] [Full Text] [Related]

  • 4. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G.
    Cancer; 2007 Mar 01; 109(5):882-90. PubMed ID: 17262824
    [Abstract] [Full Text] [Related]

  • 5. Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence.
    Susini T, Rapi S, Massi D, Savino L, Amunni G, Taddei GL, Massi G.
    Cancer; 1999 Sep 15; 86(6):1005-12. PubMed ID: 10491527
    [Abstract] [Full Text] [Related]

  • 6. Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation.
    el-Naggar AK, Abdul-Karim FW, Silva EG, McLemore D, Garnsey L.
    Hum Pathol; 1991 Sep 15; 22(9):897-903. PubMed ID: 1916750
    [Abstract] [Full Text] [Related]

  • 7. Neoplasms of endometrial stroma: histopathologic and flow cytometric analysis with clinical correlation.
    August CZ, Bauer KD, Lurain J, Murad T.
    Hum Pathol; 1989 Mar 15; 20(3):232-7. PubMed ID: 2722173
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
    Sampedro A, Salas-Bustamante A, López-Artimez M, García-Muñíz JL, Urdiales G.
    Anal Quant Cytol Histol; 1999 Aug 15; 21(4):347-52. PubMed ID: 10560513
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L, Conti L, Antenucci A, Vercillo M, Atlante M, Gandolfo GM.
    Anticancer Res; 2000 Aug 15; 20(5B):3569-74. PubMed ID: 11131664
    [Abstract] [Full Text] [Related]

  • 10. Tumor cell cycle in patients with stage I endometrial carcinoma.
    Vecek N, Nola M, Marusić M, Babić D, Uzarević B, Sabioncello A, Petrovecki M, Ljubić-Racunica N, Marinović T.
    Gynecol Oncol; 1994 Apr 15; 53(1):38-43. PubMed ID: 8175020
    [Abstract] [Full Text] [Related]

  • 11. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
    Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Tropé CG.
    Gynecol Oncol; 1996 Aug 15; 62(2):254-9. PubMed ID: 8751558
    [Abstract] [Full Text] [Related]

  • 12. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A, Bell DA, Rice LW.
    Gynecol Oncol; 1993 Dec 15; 51(3):355-61. PubMed ID: 8112645
    [Abstract] [Full Text] [Related]

  • 13. Molecular and histopathologic predictors of distant failure in endometrial cancer.
    Mariani A, Sebo TJ, Webb MJ, Riehle D, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC.
    Cancer Detect Prev; 2003 Dec 15; 27(6):434-41. PubMed ID: 14642551
    [Abstract] [Full Text] [Related]

  • 14. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR.
    Gynecol Oncol; 1993 Jul 15; 50(1):20-4. PubMed ID: 8349159
    [Abstract] [Full Text] [Related]

  • 15. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN, Atkinson BF, Balsara GR, Hernandez E, Jhala NC.
    Ann Diagn Pathol; 2001 Oct 15; 5(5):267-73. PubMed ID: 11598854
    [Abstract] [Full Text] [Related]

  • 16. Low-grade stromal sarcoma: DNA flow cytometric analysis and estrogen progesterone receptor data.
    Dunton CJ, Kelsten ML, Brooks SE, Viglione MJ, Carlson JA, Mikuta JJ.
    Gynecol Oncol; 1990 May 15; 37(2):268-75. PubMed ID: 2344973
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG, Norén H, Delle U.
    Gynecol Oncol; 1994 Apr 15; 53(1):64-9. PubMed ID: 8175025
    [Abstract] [Full Text] [Related]

  • 18. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W, Hua K, Malpica A, Zhou X, Baak JP.
    Int J Gynecol Cancer; 2013 Mar 15; 23(3):488-93. PubMed ID: 23435438
    [Abstract] [Full Text] [Related]

  • 19. Primary sarcomas of the kidney. A clinicopathologic and DNA flow cytometric study of 17 cases.
    Grignon DJ, Ayala AG, Ro JY, el-Naggar A, Papadopoulos NJ.
    Cancer; 1990 Apr 01; 65(7):1611-8. PubMed ID: 2155701
    [Abstract] [Full Text] [Related]

  • 20. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases].
    Shi JL, Cheng NH, Guo LN, Lian LJ.
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug 01; 40(8):517-22. PubMed ID: 22169638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.